-
Sanofi’s FDA Nod in Hemophilia Gives Patients More Convenience, Brings Roche New Competition
Sanofi’s FDA Nod in Hemophilia Gives Patients More Convenience, Brings Roche New Competition FDA approval of Sanofi hemophilia A drug Altuviiio provides patients with a therapeutic option that lasts longer than most other products available, including one already marketed by the French pharma giant. Altuviiio also gives Sanofi a way to better compete against blockbuster…
-
Report: Medicare Advantage Enrollment Sees Continued Growth, but at a Slower Rate
Report: Medicare Advantage Enrollment Sees Continued Growth, but at a Slower Rate Enrollment in Medicare Advantage plans increased by 5.5% this year, or by 1.5 million beneficiaries, according to The Chartis Group. But in 2020, 2021 and 2022, enrollment rose by 1.9 million, 2.2 million and 2.3 million, respectively. Information Courtesy By: Marissa Plescia, #HealthcareNews…
-
LGBTQ+ Health Advocates Sound Alarm Over CDC Data On American Youth
LGBTQ+ Health Advocates Sound Alarm Over CDC Data On American Youth In 2021, 69% of LGBQ+ teens reported experiencing persistent feelings of sadness or hopelessness in the past year, compared to 35% of heterosexual teens, according to a recent CDC report. This stat is likely understated because the report did not include information about those…
-
3 reasons Why Natural Language Processing Will go Mainstream This Year
3 reasons Why Natural Language Processing Will go Mainstream This Year NLP in healthcare can accurately give voice to the massive amount of unstructured data of the healthcare universe, and here are the three reasons why I believe 2023 is the year that we will see increased adoption of NLP across the industry. Information Courtesy…
-
Industrial Scale Microbiome Mining is a New Drug Discovery Toolbox
Industrial Scale Microbiome Mining is a New Drug Discovery Toolbox Within ten years of execution and widespread adoption, most pipelines will be traced to the opportunity of untapped microbes of the earth. Information Courtesy By: Ross Youngs, #HealthcareNews #Healthcare | Feeds Within ten years of execution and widespread adoption, most pipelines will be traced to…
-
Improving Value-based Care with Optimized Drug Therapy
Improving Value-based Care with Optimized Drug Therapy Optimizing drug routines allows prescribers to make more informed decisions that reduce risk and improve quality of care. The result is better outcomes for both patients and organizations. Information Courtesy By: Michael S. Awadalla, #HealthcareNews #Healthcare | Feeds Optimizing drug routines allows prescribers to make more informed decisions…
-
AbbVie Pays Capsida $70M to Expand Gene Therapy Alliance to Eye Diseases
AbbVie Pays Capsida $70M to Expand Gene Therapy Alliance to Eye Diseases AbbVie and Capsida Therapeutics are expanding their gene therapy R&D alliance to the eyes. Capsida is in line to receive $70 million now and up to $595 million later, depending on the progress of the eye programs. Information Courtesy By: Frank Vinluan, #HealthcareNews…
Got any book recommendations?